Animal trials of Bharat Biotech International Limited’s Covid-19 vaccine candidate, Covaxin, have been successful and results showed the injection’s “remarkable immunogenicity and protective efficacy” in phase I clinical trials in India, the manufacturer said. of medications. Covaxin, developed by the Indian Council for Medical Research (ICMR) and Bharat Biotech, is …
Read More »
In this illustration, taken on April 10, 2020, small vials labeled with a “COVID-19 Vaccine” label and a medical syringe are seen (REUTERS / Dado Ruvic / Illustration / File photo). The Serum Institute of India halted trials of the Covid-19 vaccine in India one day after AstraZeneca halted trials …
Read More »
A staff member places a Sinovac Biotech Ltd coronavirus vaccine candidate on its booth for display during the 2020 China International Trade in Services Fair (CIFTIS), following the COVID-19 outbreak, in Beijing, China, on September 5, 2020. REUTERS / Tingshu Wang UN Secretary General Antonio Guterres urged countries to find …
Read More »
The Serum Institute of India said it will halt the Phrase 3 trials that were due to start in India next week. New Delhi: The Serum Institute of India, which is manufacturing the Covishield coronavirus vaccine being developed by the University of Oxford in conjunction with major pharmaceutical company AstraZenca, …
Read More »
The letter said the trial showed that multiple participants reported identical antibody levels (representative) Moscow: Twenty-six scientists, most of them working at Italian universities, signed an open letter questioning the reliability of the data presented in the results of the initial trial of the Russian COVID-19 vaccine, called “Sputnik-V”. Addressing …
Read More »
The Serum Institute of India (SII) said on Wednesday that the drugmaker will follow instructions from the central drug regulator on suspending the Oxford-AstraZeneca COVID-19 vaccine trial in India. The Controller General of Drugs of India (DCGI) issued a notice of demonstrative cause to the Serum Institute of India on …
Read More »
HYDERABAD: Russia, seeking to produce large doses of its Covid-19 Sputnik V vaccine for global supply, is knocking on the doors of vaccine manufacturers in Hyderabad. Representatives of the Russian Direct Investment Fund (RDIF), which has been involved in the development of Sputnik V, has reached out to the city’s …
Read More »
Even as AstraZeneca has paused the trials of its Covid-19 vaccine candidate after one of the participants in the UK developed an unexplained illness, more than 100 volunteers in India have completed the crucial week after receiving injections in the trials in phase two humans showing no adverse reaction. . …
Read More »
The vaccine, which AstraZeneca is developing, has been considered a leading candidate. AstraZeneca Plc stopped giving injections of its experimental coronavirus vaccine after a person participating in one of the company’s studies fell ill, a possible adverse reaction that could delay or derail efforts to speed up an immunization against …
Read More »
NEW DELHI: Russia has approached India to seek the collaboration of Indian companies in the manufacture of Covid-19 vaccines and also if phase 3 or bridge studies could be conducted here. The Center said there has been significant movement on both fronts. The disclosure has spread to many companies and …
Read More »